The global Fostamatinib market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
Tavalisse segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Fostamatinib include Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Fostamatinib manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Fostamatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fostamatinib. This report contains market size and forecasts of Fostamatinib in global, including the following market information:
Global Fostamatinib market revenue, 2020-2025, 2026-2032, ($ millions)
Global Fostamatinib market sales, 2020-2025, 2026-2032, (K Bottles)
Global top five Fostamatinib companies in 2024 (%)
Total Market by Segment:
Global Fostamatinib market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Bottles)
Global Fostamatinib market segment percentages, by Type, 2024 (%)
Tavalisse
Tavlesse
Global Fostamatinib market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Bottles)
Global Fostamatinib market segment percentages, by Application, 2024 (%)
Idiopathic (Immune) Thrombocytopenic Purpura
Waldenstr�m's Macroglobulinemia
Autoimmune Haemolytic Anaemia
Other
Global Fostamatinib market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Bottles)
Global Fostamatinib market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fostamatinib revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Fostamatinib revenues share in global market, 2024 (%)
Key companies Fostamatinib sales in global market, 2020-2025 (estimated), (K Bottles)
Key companies Fostamatinib sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Rigel Pharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
Grifols
JW Pharmaceutical Corporation
Medison Pharma Canada
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fostamatinib, market overview.
Chapter 2: Global Fostamatinib market size in revenue and volume.
Chapter 3: Detailed analysis of Fostamatinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fostamatinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fostamatinib capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Fostamatinib Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Fostamatinib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fostamatinib Overall Market Size
2.1 Global Fostamatinib Market Size: 2024 VS 2032
2.2 Global Fostamatinib Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Fostamatinib Sales: 2020-2032
3 Company Landscape
3.1 Top Fostamatinib Players in Global Market
3.2 Top Global Fostamatinib Companies Ranked by Revenue
3.3 Global Fostamatinib Revenue by Companies
3.4 Global Fostamatinib Sales by Companies
3.5 Global Fostamatinib Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Fostamatinib Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Fostamatinib Product Type
3.8 Tier 1, Tier 2, and Tier 3 Fostamatinib Players in Global Market
3.8.1 List of Global Tier 1 Fostamatinib Companies
3.8.2 List of Global Tier 2 and Tier 3 Fostamatinib Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Fostamatinib Market Size Markets, 2024 & 2032
4.1.2 Tavalisse
4.1.3 Tavlesse
4.2 Segment by Type - Global Fostamatinib Revenue & Forecasts
4.2.1 Segment by Type - Global Fostamatinib Revenue, 2020-2025
4.2.2 Segment by Type - Global Fostamatinib Revenue, 2026-2032
4.2.3 Segment by Type - Global Fostamatinib Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Fostamatinib Sales & Forecasts
4.3.1 Segment by Type - Global Fostamatinib Sales, 2020-2025
4.3.2 Segment by Type - Global Fostamatinib Sales, 2026-2032
4.3.3 Segment by Type - Global Fostamatinib Sales Market Share, 2020-2032
4.4 Segment by Type - Global Fostamatinib Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Fostamatinib Market Size, 2024 & 2032
5.1.2 Idiopathic (Immune) Thrombocytopenic Purpura
5.1.3 Waldenstr�m's Macroglobulinemia
5.1.4 Autoimmune Haemolytic Anaemia
5.1.5 Other
5.2 Segment by Application - Global Fostamatinib Revenue & Forecasts
5.2.1 Segment by Application - Global Fostamatinib Revenue, 2020-2025
5.2.2 Segment by Application - Global Fostamatinib Revenue, 2026-2032
5.2.3 Segment by Application - Global Fostamatinib Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Fostamatinib Sales & Forecasts
5.3.1 Segment by Application - Global Fostamatinib Sales, 2020-2025
5.3.2 Segment by Application - Global Fostamatinib Sales, 2026-2032
5.3.3 Segment by Application - Global Fostamatinib Sales Market Share, 2020-2032
5.4 Segment by Application - Global Fostamatinib Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Fostamatinib Market Size, 2024 & 2032
6.2 By Region - Global Fostamatinib Revenue & Forecasts
6.2.1 By Region - Global Fostamatinib Revenue, 2020-2025
6.2.2 By Region - Global Fostamatinib Revenue, 2026-2032
6.2.3 By Region - Global Fostamatinib Revenue Market Share, 2020-2032
6.3 By Region - Global Fostamatinib Sales & Forecasts
6.3.1 By Region - Global Fostamatinib Sales, 2020-2025
6.3.2 By Region - Global Fostamatinib Sales, 2026-2032
6.3.3 By Region - Global Fostamatinib Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Fostamatinib Revenue, 2020-2032
6.4.2 By Country - North America Fostamatinib Sales, 2020-2032
6.4.3 United States Fostamatinib Market Size, 2020-2032
6.4.4 Canada Fostamatinib Market Size, 2020-2032
6.4.5 Mexico Fostamatinib Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Fostamatinib Revenue, 2020-2032
6.5.2 By Country - Europe Fostamatinib Sales, 2020-2032
6.5.3 Germany Fostamatinib Market Size, 2020-2032
6.5.4 France Fostamatinib Market Size, 2020-2032
6.5.5 U.K. Fostamatinib Market Size, 2020-2032
6.5.6 Italy Fostamatinib Market Size, 2020-2032
6.5.7 Russia Fostamatinib Market Size, 2020-2032
6.5.8 Nordic Countries Fostamatinib Market Size, 2020-2032
6.5.9 Benelux Fostamatinib Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Fostamatinib Revenue, 2020-2032
6.6.2 By Region - Asia Fostamatinib Sales, 2020-2032
6.6.3 China Fostamatinib Market Size, 2020-2032
6.6.4 Japan Fostamatinib Market Size, 2020-2032
6.6.5 South Korea Fostamatinib Market Size, 2020-2032
6.6.6 Southeast Asia Fostamatinib Market Size, 2020-2032
6.6.7 India Fostamatinib Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Fostamatinib Revenue, 2020-2032
6.7.2 By Country - South America Fostamatinib Sales, 2020-2032
6.7.3 Brazil Fostamatinib Market Size, 2020-2032
6.7.4 Argentina Fostamatinib Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Fostamatinib Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Fostamatinib Sales, 2020-2032
6.8.3 Turkey Fostamatinib Market Size, 2020-2032
6.8.4 Israel Fostamatinib Market Size, 2020-2032
6.8.5 Saudi Arabia Fostamatinib Market Size, 2020-2032
6.8.6 UAE Fostamatinib Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Rigel Pharmaceuticals, Inc
7.1.1 Rigel Pharmaceuticals, Inc Company Summary
7.1.2 Rigel Pharmaceuticals, Inc Business Overview
7.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Major Product Offerings
7.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Sales and Revenue in Global (2020-2025)
7.1.5 Rigel Pharmaceuticals, Inc Key News & Latest Developments
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales and Revenue in Global (2020-2025)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Fostamatinib Major Product Offerings
7.3.4 Grifols Fostamatinib Sales and Revenue in Global (2020-2025)
7.3.5 Grifols Key News & Latest Developments
7.4 JW Pharmaceutical Corporation
7.4.1 JW Pharmaceutical Corporation Company Summary
7.4.2 JW Pharmaceutical Corporation Business Overview
7.4.3 JW Pharmaceutical Corporation Fostamatinib Major Product Offerings
7.4.4 JW Pharmaceutical Corporation Fostamatinib Sales and Revenue in Global (2020-2025)
7.4.5 JW Pharmaceutical Corporation Key News & Latest Developments
7.5 Medison Pharma Canada
7.5.1 Medison Pharma Canada Company Summary
7.5.2 Medison Pharma Canada Business Overview
7.5.3 Medison Pharma Canada Fostamatinib Major Product Offerings
7.5.4 Medison Pharma Canada Fostamatinib Sales and Revenue in Global (2020-2025)
7.5.5 Medison Pharma Canada Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Fostamatinib Major Product Offerings
7.6.4 AstraZeneca Fostamatinib Sales and Revenue in Global (2020-2025)
7.6.5 AstraZeneca Key News & Latest Developments
8 Global Fostamatinib Production Capacity, Analysis
8.1 Global Fostamatinib Production Capacity, 2020-2032
8.2 Fostamatinib Production Capacity of Key Manufacturers in Global Market
8.3 Global Fostamatinib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fostamatinib Supply Chain Analysis
10.1 Fostamatinib Industry Value Chain
10.2 Fostamatinib Upstream Market
10.3 Fostamatinib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fostamatinib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Fostamatinib in Global Market
Table 2. Top Fostamatinib Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Fostamatinib Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Fostamatinib Revenue Share by Companies, 2020-2025
Table 5. Global Fostamatinib Sales by Companies, (K Bottles), 2020-2025
Table 6. Global Fostamatinib Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Fostamatinib Price (2020-2025) & (US$/Bottle)
Table 8. Global Manufacturers Fostamatinib Product Type
Table 9. List of Global Tier 1 Fostamatinib Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fostamatinib Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Fostamatinib Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Fostamatinib Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Fostamatinib Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Fostamatinib Sales (K Bottles), 2020-2025
Table 15. Segment by Type - Global Fostamatinib Sales (K Bottles), 2026-2032
Table 16. Segment by Application � Global Fostamatinib Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Fostamatinib Sales, (K Bottles), 2020-2025
Table 20. Segment by Application - Global Fostamatinib Sales, (K Bottles), 2026-2032
Table 21. By Region � Global Fostamatinib Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Fostamatinib Sales, (K Bottles), 2020-2025
Table 25. By Region - Global Fostamatinib Sales, (K Bottles), 2026-2032
Table 26. By Country - North America Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Fostamatinib Sales, (K Bottles), 2020-2025
Table 29. By Country - North America Fostamatinib Sales, (K Bottles), 2026-2032
Table 30. By Country - Europe Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Fostamatinib Sales, (K Bottles), 2020-2025
Table 33. By Country - Europe Fostamatinib Sales, (K Bottles), 2026-2032
Table 34. By Region - Asia Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Fostamatinib Sales, (K Bottles), 2020-2025
Table 37. By Region - Asia Fostamatinib Sales, (K Bottles), 2026-2032
Table 38. By Country - South America Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Fostamatinib Sales, (K Bottles), 2020-2025
Table 41. By Country - South America Fostamatinib Sales, (K Bottles), 2026-2032
Table 42. By Country - Middle East & Africa Fostamatinib Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Fostamatinib Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Fostamatinib Sales, (K Bottles), 2020-2025
Table 45. By Country - Middle East & Africa Fostamatinib Sales, (K Bottles), 2026-2032
Table 46. Rigel Pharmaceuticals, Inc Company Summary
Table 47. Rigel Pharmaceuticals, Inc Fostamatinib Product Offerings
Table 48. Rigel Pharmaceuticals, Inc Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) & (2020-2025)
Table 49. Rigel Pharmaceuticals, Inc Key News & Latest Developments
Table 50. Kissei Pharmaceutical Co., Ltd Company Summary
Table 51. Kissei Pharmaceutical Co., Ltd Fostamatinib Product Offerings
Table 52. Kissei Pharmaceutical Co., Ltd Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) & (2020-2025)
Table 53. Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Fostamatinib Product Offerings
Table 56. Grifols Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) & (2020-2025)
Table 57. Grifols Key News & Latest Developments
Table 58. JW Pharmaceutical Corporation Company Summary
Table 59. JW Pharmaceutical Corporation Fostamatinib Product Offerings
Table 60. JW Pharmaceutical Corporation Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) & (2020-2025)
Table 61. JW Pharmaceutical Corporation Key News & Latest Developments
Table 62. Medison Pharma Canada Company Summary
Table 63. Medison Pharma Canada Fostamatinib Product Offerings
Table 64. Medison Pharma Canada Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) & (2020-2025)
Table 65. Medison Pharma Canada Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Fostamatinib Product Offerings
Table 68. AstraZeneca Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) & (2020-2025)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Fostamatinib Capacity of Key Manufacturers in Global Market, 2023-2025 (K Bottles)
Table 71. Global Fostamatinib Capacity Market Share of Key Manufacturers, 2023-2025
Table 72. Global Fostamatinib Production by Region, 2020-2025 (K Bottles)
Table 73. Global Fostamatinib Production by Region, 2026-2032 (K Bottles)
Table 74. Fostamatinib Market Opportunities & Trends in Global Market
Table 75. Fostamatinib Market Drivers in Global Market
Table 76. Fostamatinib Market Restraints in Global Market
Table 77. Fostamatinib Raw Materials
Table 78. Fostamatinib Raw Materials Suppliers in Global Market
Table 79. Typical Fostamatinib Downstream
Table 80. Fostamatinib Downstream Clients in Global Market
Table 81. Fostamatinib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fostamatinib Product Picture
Figure 2. Fostamatinib Segment by Type in 2024
Figure 3. Fostamatinib Segment by Application in 2024
Figure 4. Global Fostamatinib Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Fostamatinib Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Fostamatinib Revenue: 2020-2032 (US$, Mn)
Figure 8. Fostamatinib Sales in Global Market: 2020-2032 (K Bottles)
Figure 9. The Top 3 and 5 Players Market Share by Fostamatinib Revenue in 2024
Figure 10. Segment by Type � Global Fostamatinib Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Fostamatinib Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Fostamatinib Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Fostamatinib Price (US$/Bottle), 2020-2032
Figure 14. Segment by Application � Global Fostamatinib Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Fostamatinib Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Fostamatinib Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Fostamatinib Price (US$/Bottle), 2020-2032
Figure 18. By Region � Global Fostamatinib Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Fostamatinib Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Fostamatinib Revenue Market Share, 2020-2032
Figure 21. By Region - Global Fostamatinib Sales Market Share, 2020-2032
Figure 22. By Country - North America Fostamatinib Revenue Market Share, 2020-2032
Figure 23. By Country - North America Fostamatinib Sales Market Share, 2020-2032
Figure 24. United States Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Fostamatinib Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Fostamatinib Sales Market Share, 2020-2032
Figure 29. Germany Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 30. France Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Fostamatinib Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Fostamatinib Sales Market Share, 2020-2032
Figure 38. China Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 42. India Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Fostamatinib Revenue Market Share, 2020-2032
Figure 44. By Country - South America Fostamatinib Sales, Market Share, 2020-2032
Figure 45. Brazil Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Fostamatinib Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Fostamatinib Sales, Market Share, 2020-2032
Figure 49. Turkey Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Fostamatinib Revenue, (US$, Mn), 2020-2032
Figure 53. Global Fostamatinib Production Capacity (K Bottles), 2020-2032
Figure 54. The Percentage of Production Fostamatinib by Region, 2024 VS 2032
Figure 55. Fostamatinib Industry Value Chain
Figure 56. Marketing Channels
